glp-1 and ms GLP-1s Multiple Sclerosis Episode 444: A GLP-1 Drug

Start with a lower dose than patients reported compounded drug dose and titrate up slowly, Basina said

SGLT-2 inhibitors were associated with lower risk of renal outcome as compared with placebo (36% lower risk), DPP-4 inhibitors (40% lower risk) and GLP-1RA (22% lower risk)

Mounjaro and Zepbound are both protected from generic competition, giving Eli Lilly full control over pricing with no market pressure to bring costs down

While this is one of the expected effects in terms of weight management, excessive dietary restriction can lead to nutritional deficiencies

Several real-world studies based on administrative data and pharmacy reports have demonstrated that reduced adherence to antidiabetic therapy is associated not only with poorer glycemic control but also with a significant increase in overall mortality and hospitalizations for all causes [70, 71]